IHS Chemical Week

Regions :: Western Europe :: U.K.

Pfizer walks away from AstraZeneca bid

1:41 PM MDT | May 27, 2014 | Natasha Alperowicz

Pfizer confirmed today that its “informal” offer to acquire AstraZeneca for £69.4 billion (117 billion) has lapsed and that it was consequently withdrawing the offer. This decision follows the expiry, at 5:00 pm BST, of a 28-day “put up or shut up” deadline under UK takeover rules by which Pfizer was required to make a firm offer to AstraZeneca shareholders. Pfizer made an “informal” but “final” offer of £55/share in cash and Pfizer shares on 19 May for AstraZeneca; that offer was rejected by the UK...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa